ASPI

ASP Isotopes Inc.

2026-01-16 03:02 PM

+2.34%

ASP Isotopes continues gains following Renergen deal completion

ASPI extended its rally for a second consecutive day following the completion of its $5 million acquisition of a 10% stake in Renergen's Tetra4 subsidiary. The deal, announced January 15, includes ASPI's commitment to help secure $750 million in expansion funding for South Africa's first commercial liquid helium plant.

Analysis

This appears to be continued momentum from yesterday's larger gain on the same news, rather than a new catalyst. The very light volume (0.3x normal) suggests this is residual buying interest rather than fresh institutional activity. The stock has now recovered most of the pullback seen earlier in the week, with back-to-back gains totaling roughly 8% since the deal closed.

Sources

ASP Isotopes Inc. (ASPI) closes Renergen deal, unlocking $750M in funding for helium expansion

Date: 2026-01-16

Price: $7.63

Type: Stock Specific

Confidence: medium